Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Eczema (Atopic Dermatitis) Clinical Trials

A listing of Eczema (Atopic Dermatitis) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (121) clinical trials

Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Atopic Dermatitis

Up to 40 healthy and 40 atopic dermatitis subjects meeting the inclusion criteria will be enrolled. Medical records will be reviewed pertaining to the subject's diagnosis of atopic dermatitis and specific therapeutic interventions. For atopic dermatitis subjects, AD severity will be assessed using Eczema Area and Severity Index (EASI). Study ...

Phase N/A

Disease Trajectories in Atopic Dermatitis and Psoriasis

Atopic dermatitis and psoriasis are the most common chronic inflammatory skin diseases in dermatology. Due to genetic predispositions, inflammatory changes of the skin occur. The specific immunological inflammatory mechanisms are partly understood for both diseases and targeted therapies are established in psoriasis therapy and are currently available for the first ...

Phase N/A

Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis

Psoriasis is a chronic autoimmune disorder of the skin. In this disease, the inflammatory caspases, cysteine proteases involved in the processing of many proteins, are activated. Transgenic mice expressing the cleaved form of caspases by Lyn, a tyrosine kinase Src family, develop an inflammatory syndrome with the characteristics of human ...

Phase N/A

Systemic Therapies for Pediatric Atopic Dermatitis

Severe and/or refractory cases of atopic dermatitis (AD) can require systemic immunosuppressive therapy for disease control, yet there are few studies regarding the appropriate use of these drugs for pediatric AD and even less data comparing them. The current observational study will observe the effect of these therapies on children ...

Phase N/A

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Registry study to examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Phase N/A

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Skin microbiota (bacteria, fungi, viruses, phage, archae) play a significant role in common dermatological conditions, such as atopic dermatitis/AD (eczema). Since culture-dependent methods are often biased assessments of microbial diversity, genomic methods can expand our understanding of the human microbiome and skin diseases. Chronic dermatitis is typical among rare primary ...

Phase N/A

Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

To evaluate adherence to topical therapy using adherence data collected by the MEMS cap (Medication Electronic Monitoring System) in pediatric patients with atopic dermatitis (AD) and the impact of a return visit.


Common Allergens in Skin Tests for Adult Atopic Dermatitis

The allergens involved in atopic patients are widely existed in our environment. Traditionally, we use serum specific IgE, skin prick test or intradermal test to verify the possible causative allergens in patients with atopic dermatitis. This study will evaluate the correlation between serum specific IgE, skin prick test, intradermal test, ...

Phase N/A

Blood Urine and Tissue Collection for Cutaneous Lymphoma Eczema and Atopic Dermatitis Research

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: immunologic assays/flow cytometry tumor progression/regression genomic studies proteomic studies others germane to the advancement of CTCL treatment

Phase N/A

Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis

The purpose of this study is to assess the efficacy and tolerability of short-term treatment with fluocinonide cream 0.1% (Vanos®) in the treatment of atopic dermatitis (AD). Our hypothesis is that subjects will have a reduction in Investigator's Global Assessment scores at Day 7 and Day 14 compared to Baseline. ...

Phase N/A